Mannkind Corp (MNKD)

May 27, 2025

MannKind: Why I'm Still Bullish Despite Tyvaso DPI Competition - Seeking Alpha

May 27, 2025

May 20, 2025

MannKind stock touches 52-week low at $4.34 amid market shifts - Investing.com Canada

May 20, 2025

May 20, 2025

MannKind at RBC Conference: Strategic Growth and Innovation By Investing.com - Investing.com Canada

May 20, 2025

May 20, 2025

MannKind at RBC Conference: Strategic Growth and Innovation - Investing.com

May 20, 2025

May 20, 2025

MannKind To Present At RBC Capital Markets Conference; Webcast At 8:00 AM ET - Nasdaq

May 20, 2025

May 16, 2025

Most adults with type 1 diabetes using inhaled insulin increase daily dose over 30 weeks - Healio

May 16, 2025

May 16, 2025

MannKind EVP David Thomson sells shares worth $150,597 By Investing.com - Investing.com India

May 16, 2025

May 15, 2025

MannKind corp director Steven Binder sells $375,875 in stock By Investing.com - Investing.com Nigeria

May 15, 2025

May 15, 2025

MannKind EVP David Thomson sells shares worth $150,597 - Investing.com

May 15, 2025

May 15, 2025

MannKind corp director Steven Binder sells $375,875 in stock - Investing.com

May 15, 2025

May 15, 2025

MannKind CMO steps down, transition plan set - Investing.com

May 15, 2025

May 13, 2025

MannKind to Present at Upcoming Investor Conferences - The Globe and Mail

May 13, 2025

May 11, 2025

MannKind Corporation (NASDAQ:MNKD) Q1 2025 Earnings Call Transcript - Insider Monkey

May 11, 2025

May 09, 2025

MannKind Corporation (MNKD): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey

May 09, 2025

May 09, 2025

Decoding MannKind Corp (MNKD): A Strategic SWOT Insight - GuruFocus

May 09, 2025

May 08, 2025

10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey

May 08, 2025

May 08, 2025

MannKind: Q1 Earnings Snapshot - MySA

May 08, 2025

May 08, 2025

Earnings call transcript: MannKind Q1 2025 revenue beats, stock dips - Investing.com

May 08, 2025

May 08, 2025

MannKind (MNKD) Surpasses Q1 Revenue Expectations with Strong Gr - GuruFocus

May 08, 2025

May 08, 2025

MannKind (MNKD) Surpasses Q1 Revenue Expectations with Strong Growth | MNKD Stock News - GuruFocus

May 08, 2025

May 08, 2025

MannKind Corp Q1 2025 Earnings: EPS Meets Estimates at $0.04, Revenue Surpasses Expectations at $78 Million - GuruFocus

May 08, 2025

May 08, 2025

MannKind Corporation Reports First Quarter 2025 Financial Results - TradingView

May 08, 2025

May 08, 2025

MANNKIND CORP SEC 10-Q Report - TradingView

May 08, 2025

May 08, 2025

MannKind Corporation Reports First Quarter 2025 Financial Results and Provides Business Update - Yahoo Finance

May 08, 2025

May 07, 2025

MannKind Corp (MNKD) Q1 2025 Earnings Report Preview: What To Ex - GuruFocus

May 07, 2025

May 07, 2025

MannKind Corp (MNKD) Q1 2025 Earnings Report Preview: What To Expect - Yahoo Finance

May 07, 2025

May 01, 2025

MannKind Corporation to Hold 2025 First Quarter Financial Results Conference Call on May 8, 2025 - The Globe and Mail

May 01, 2025

Apr 29, 2025

The Potential Rise in the Price of Mannkind Corp (MNKD) following insiders activity - knoxdaily.com

Apr 29, 2025

Apr 29, 2025

Solidion Technology Inc’s latest rating changes from various analysts - knoxdaily.com

Apr 29, 2025

Apr 23, 2025

MNKD (Mannkind Corp) may reap gains as insiders became active recently - knoxdaily.com

Apr 23, 2025

Apr 23, 2025

Mannkind Corp (MNKD) is looking forward to a strong quarter - Sete News

Apr 23, 2025

Apr 18, 2025

Is MannKind Corporation (MNKD) the Best Quality Penny Stock to Buy According to Hedge Funds? (READY TO EDIT2) - Insider Monkey

Apr 18, 2025

Apr 16, 2025

Is MannKind Corp. (NASDAQ:MNKD) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey

Apr 16, 2025

Apr 15, 2025

13 Best Biotech Penny Stocks to Buy According to Hedge Funds - Insider Monkey

Apr 15, 2025

Apr 12, 2025

MannKind (NASDAQ:MNKD) Upgraded at Mizuho - Defense World

Apr 12, 2025

Apr 10, 2025

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Apr 10, 2025

Apr 09, 2025

Mizuho sets MannKind stock Outperform with $12 target - Investing.com

Apr 09, 2025

Apr 09, 2025

Mizuho sets MannKind stock Outperform with $12 target By Investing.com - Investing.com India

Apr 09, 2025

Apr 07, 2025

Diabetes Meets Racing: MannKind's Game-Changing Partnership With Type 1 Diabetic IndyCar Star - Stock Titan

Apr 07, 2025

Apr 07, 2025

MannKind To Support Conor Daly - Speed Sport

Apr 07, 2025

Apr 07, 2025

MannKind Teams Up with Juncos Hollinger Racing (JHR) Driver Conor Daly to Drive Awareness of Diabetes and Innovative Treatment Options - Yahoo Finance

Apr 07, 2025

Mar 28, 2025

FTNT Stock Sees Surge of Approximately 1.11% in Last Five Days - knoxdaily.com

Mar 28, 2025

Mar 25, 2025

Why It's Worth Keeping An Eye On MannKind - RTTNews

Mar 25, 2025

Mar 21, 2025

Cantor maintains Overweight rating on MannKind stock at $9 target - Investing.com

Mar 21, 2025